1. Synthesis and Pharmacological Evaluation of New
- Author
-
Paloma, Narros-Fernández, Mourad, Chioua, Sonia A, Petcu, Daniel, Diez-Iriepa, Laura, Cerrada-Gálvez, Céline, Decouty-Pérez, Alejandra, Palomino-Antolín, Eva, Ramos, Víctor, Farré-Alins, Ana Belén, López-Rodríguez, Alejandro, Romero, José, Marco-Contelles, and Javier, Egea
- Subjects
Mice, Inbred C57BL ,Mice ,Gout ,Hyperalgesia ,Inflammasomes ,Interleukin-1beta ,NLR Family, Pyrin Domain-Containing 3 Protein ,Anti-Inflammatory Agents ,Animals - Abstract
NLRP3 is involved in the pathophysiology of several inflammatory diseases. Therefore, there is high current interest in the clinical development of new NLRP3 inflammasome small inhibitors to treat these diseases. Novel
- Published
- 2022